-
公开(公告)号:EP4426692A1
公开(公告)日:2024-09-11
申请号:EP22889573.6
申请日:2022-11-06
发明人: LISTOVSKY, Tamar , TOBI, Dror
IPC分类号: C07D413/04 , C07D401/14 , C07D231/12 , A61K31/422 , A61K31/53 , A61K31/415 , A61P35/00
CPC分类号: A61K31/415 , A61K31/422 , A61K31/53 , A61P35/00 , C07D231/12 , C07D413/04 , C07D403/04 , A61K31/555 , A61K31/7048 , A61K31/704
-
公开(公告)号:EP3752497B1
公开(公告)日:2024-07-17
申请号:EP19709182.0
申请日:2019-02-15
IPC分类号: C07D401/14 , A61K31/404 , A61K31/415 , A61K31/4164 , A61K31/4439 , A61K31/451 , A61K31/4709 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/506 , C07D231/12 , C07D233/64 , C07D401/04 , C07D403/04
CPC分类号: C07D211/32 , C07D231/12 , C07D233/64 , C07D237/08 , C07D239/26 , C07D241/04 , C07D401/04 , C07D401/14 , C07D403/04 , A61K45/06 , A61P3/00 , A61P9/00 , A61P11/00 , A61P29/00 , A61P31/12 , A61P35/00
-
3.
公开(公告)号:EP4367098A1
公开(公告)日:2024-05-15
申请号:EP22740366.4
申请日:2022-06-28
IPC分类号: C07D205/04 , C07D209/08 , C07D209/12 , C07D209/20 , C07D209/88 , C07D209/96 , C07D213/68 , C07D231/12 , C07D231/16 , C07D231/38 , C07D233/64 , C07D249/10 , C07D263/24 , C07D265/30 , C07D295/192 , C07D333/72 , C07D339/08 , C07D401/12 , C07D405/04 , C07D471/04 , C07D473/08
CPC分类号: C07D339/08 , C07D205/04 , C07C253/30 , C07C41/30 , C07C45/68 , C07C17/263 , C07C269/06 , C07D209/08 , C07D209/12 , C07D209/20 , C07D209/88 , C07D209/96 , C07D213/68 , C07D231/12 , C07D231/16 , C07D231/38 , C07D233/64 , C07D249/10 , C07D263/24 , C07D265/30 , C07D295/192 , C07D333/72 , C07D401/12 , C07D405/04 , C07D471/04 , C07D473/08 , C07D487/04 , C07D491/044 , C07B37/04 , C07B59/001 , C07B59/002 , C07B59/004 , C07B37/02 , C07B43/02 , C07C1/322
-
公开(公告)号:EP4346411A1
公开(公告)日:2024-04-10
申请号:EP22732029.8
申请日:2022-05-24
发明人: SCARBOROUGH, Christopher Charles , EDMUNDS, Andrew , BIGOT, Aurelien , LAMBERTH, Clemens , STIERLI, Daniel , EL QACEMI, Myriem , MAHAJAN, Atul , COMPAGNONE, Nicola , LUMBROSO, Alexandre Franco Jean Camille , WILLIAMS, Simon , JUNG, Pierre Joseph Marcel , FINKBEINER, Peter , POULIOT, Martin
IPC分类号: A01N43/56 , A01N43/653 , A01N43/76 , A01N43/80 , A01N43/82 , A01N43/84 , A01P3/00 , C07D217/06 , C07D231/14 , C07D249/10 , C07D261/10 , C07D271/06 , C07D277/06 , C07D285/08 , C07D217/00 , C07D231/12
-
公开(公告)号:EP4308115A1
公开(公告)日:2024-01-24
申请号:EP22771979.6
申请日:2022-03-14
发明人: CHILDERS, Kaleen Konrad , ELLIS, J. Michael , FULLER, Peter, J. , GUNAYDIN, Hakan , SCOTT, Jack, D. , TANG, Haiqun , YEUNG, Charles, S.
IPC分类号: A61K31/415 , A61K31/4155 , A61K31/427 , C07D231/10 , C07D231/12 , C07D231/14
-
公开(公告)号:EP4305022A1
公开(公告)日:2024-01-17
申请号:EP22712611.7
申请日:2022-03-11
发明人: KIRKHAM, James , COOPER, Ian , BUNT, Adam , BLADES, Kevin , ORR, David , WILKINSON, Andrew , SCHOFIELD, Paul
IPC分类号: C07D207/06 , C07D211/08 , C07D231/12 , C07D243/14 , C07D295/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D407/04 , C07D407/14 , C07D409/12 , C07D413/04 , A61P31/12 , A61K31/4965
-
公开(公告)号:EP4288412A1
公开(公告)日:2023-12-13
申请号:EP22711603.5
申请日:2022-02-07
发明人: TRAINOR, George, L. , RABAL GRACIA, Maria, Obdulia , FOURMOIS, Laura , GHERBOVET, Olga , CACHOUX, Frederic
IPC分类号: C07C311/17 , C07C311/18 , C07D207/09 , C07D207/10 , C07D211/96 , C07D213/62 , C07D231/12 , C07D241/04 , C07D265/30 , C07D307/04 , C07D307/52 , C07D333/08 , C07D333/28 , C07D401/12 , C07D487/18 , A61P29/00 , A61P35/00 , A61K31/19
-
公开(公告)号:EP4284783A1
公开(公告)日:2023-12-06
申请号:EP22704167.0
申请日:2022-01-26
申请人: FMC Corporation
发明人: ZHANG, Wenming , SANA, Kasinath , ROSSI, Michael, Alan , BOLGUNAS, Stephen, P. , TISCIONE, Myles Joseph
IPC分类号: C07D231/12 , C07D231/16 , C07D249/06 , C07D257/04 , C07D401/04 , A01N43/56 , A01N43/647 , A01N43/713
-
公开(公告)号:EP3661921B1
公开(公告)日:2023-10-18
申请号:EP18755728.5
申请日:2018-07-31
发明人: BOCK, Mark G. , WATT, Alan Paul , PORTER, Roderick Alan , HARRISON, David , BOUTARD, Nicolas Felix Pierre , TOPOLNICKI, Grzegorz Witold , FABRITIUS, Charles-Henry Robert Yves , LEVENETS, Oleksandr
IPC分类号: C07D307/87 , C07D231/12 , C07D241/12 , C07D249/08 , C07D233/56 , C07D237/08 , C07D239/26 , A61K31/343 , A61K31/415 , A61K31/4164 , A61K31/4965 , A61P29/00 , A61P37/00
-
10.
公开(公告)号:EP4245752A2
公开(公告)日:2023-09-20
申请号:EP22170028.9
申请日:2007-06-04
申请人: Techfields Inc , Yu, Chongxi
发明人: CHONGXI, Yu , XU, Lina
IPC分类号: C07D209/32 , C07D231/12 , C07D471/08 , C07D487/08 , C07D213/74 , C07D215/10 , C07D217/12 , A61K31/44 , A61P29/00 , A61P3/00
摘要: The novel positively charged pro-drugs of NSAIAs in the general formulas (1, 2a, 2b, 2c, or 2d) "Structure 1, 2a, 2b, 2c, or 2d" were designed and synthesized.
The compounds of the general formulas (1, 2a, 2b, 2c, or 2d) "Structure 1, 2a, 2b, 2c, or 2d" indicated above can be prepared from metal salts, organic base salts, or immobilized base salts of NSAIAs with suitable halide compounds. The positively chargedamino groups in the pro-drugs in this invention largely increase the solubility of the drugs in water and will bond to the negative charge on the phosphate head group of membrane. Thus, the local concentration of the outside of the membrane or skin will be very high and will facilitate the passage of these pro-drugs from a region of high concentration to a region of low concentration. This bonding will disturb the membrane a little bit and may make some room for the lipophilic portion of the pro-drug. When the molecules of membrane move, the membrane may "crack" a little bit due to the bonding of the pro-drug. This will let the pro-drug insert into the membrane. At pH 7.4, only about 99% of the amino group is protonated. When the amino group is not protonated, the bonding between the amino group of the pro-drug and the phosphate head group of the membrane will disassociate, and the pro-drug will enter the membrane completely. When the amino group of the pro-drug flips to the other side of the membrane and thus becomes protonated, then the pro-drug is pulled into the cytosol, a semi- liquid concentrated aqueous solution or suspension. These pro-drugs can be used for treating and preventing diabetes (type I or/and type II), abnormal blood glucose and lipid levels, stroke, heart attack, and other heart and vascular diseases Alzheimer's diseases, Parkinson's diseases and other neurodegenerative diseases, psoriasis, discoid lupus erythematosus, systemic lupus erythematosus (SLE), autoimmune hepatitis, multiple sclerosis (MS), and other autoimmune diseases, amyotrophic lateral sclerosis (ALS), oculopharyngeal muscular dystrophy ( OPMD), and other muscle disorders, inflamed hemorrhoids, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani, prostatitis, prostatocystitis, varicose veins, autoimmune liver inflammation, autoimmune kidney inflammation, vein inflammation and other inflammations, skin cancers, breast cancer, colon-rectum cancer, oral cancer, and other cancers, scars, abnormal vascular skin lesions, birthmarks, moles (nevi), skin tags, aging spots (liver spots), and other skin disorders. These pro-drugs can be administered transdermally without the help of skin penetration enhancers.
-
-
-
-
-
-
-
-
-